Zantac and Elspar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zantac (ranitidine hydrochloride) and Elspar (asparaginase). Common drug interactions include convulsions among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Zantac and Elspar. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Zantac?

Zantac has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 434,161 Zantac users. Check the latest studies of Zantac.

What is Elspar?

Elspar has active ingredients of asparaginase. eHealthMe is studying from 2,057 Elspar users. Check the latest studies of Elspar.



On Jul, 09, 2026

12 people who take Zantac and Elspar together, and have interactions are studied.

Zantac and Elspar drug interactions.

What are the common drug interactions of Zantac and Elspar, by gender? *:

female:

  1. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  2. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  3. Abdominal distension
  4. Abdominal pain
  5. Abdominal pain lower
  6. Acute abdomen
  7. Anaemia (lack of blood)
  8. Blood culture positive
  9. Blood pressure decreased
  10. Cardiac disorder

male:

  1. Abdominal pain
  2. Abscess bacterial (collection of pus caused by bacteria)
  3. Cardiomegaly (increased size of heart than normal)
  4. Catheter related infection
  5. Clostridium colitis (inflammation of colon by clostridium difficile bacteria infection)
  6. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  7. Dyspnoea (difficult or laboured respiration)
  8. Enterococcal infection
  9. Febrile neutropenia (fever with reduced white blood cells)
  10. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

What are the common drug interactions of Zantac and Elspar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Abdominal distension
  2. Abdominal pain
  3. Anaemia (lack of blood)
  4. Blood pressure decreased
  5. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  6. Decreased activity
  7. Eye movement disorder
  8. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  9. Hypovolaemia (a decreased volume of circulating blood in the body)
  10. Infarction (obstruction of the blood supply to an organ or region of tissue)

10-19:

  1. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  2. Hemiparesis (weakness on one side of the body)
  3. Superior sagittal sinus thrombosis (blood clot in the dural venous sinuses, which drain blood from the brain)

20-29:

n/a

30-39:

  1. Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
  2. Parkinsonism (degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination)

40-49:

n/a

50-59:

n/a

60+:

  1. Abdominal pain lower
  2. Acute abdomen
  3. Faecal occult blood (blood clot in stool)
  4. Gastrointestinal perforation (hole in the digestive tract)
  5. Hyperammonaemia
  6. Intestinal obstruction
  7. Pancreatitis (inflammation of pancreas)
  8. Pneumonia
  9. Pyrexia (fever)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Zantac and Elspar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zantac and Elspar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zantac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Elspar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zantac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elspar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine hydrochloride and asparaginase (the active ingredients of Zantac and Elspar, respectively), and Zantac and Elspar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: